Dr. Bruce Werber: A Pioneer in Regenerative Medicine and Surgical Innovation

Dr. Bruce Werber, DPM, MS, FACFAS is a seasoned surgeon, researcher, and biotechnology entrepreneur who has dedicated over 35 years to advancing limb preservation and regenerative therapeutics. As a visionary leader at the intersection of clinical practice and biotech innovation, he has performed over 30,000 surgical procedures, earning recognition as a preeminent authority in reconstructive foot and ankle surgery. 

His career is defined by a relentless pursuit of approaches that bridge complex surgical intervention with the body’s natural healing potential. His expertise aligns seamlessly with “Bye Ol’ Dentistry” focus on biologically driven care.

“Bye Ol’ Dentistry” explores the future of biological and regenerative dentistry, blending cutting-edge science with real-world stories from clinicians reshaping patient care. Through Dr. Werber’s perspective, the film draws powerful parallels between oral health, regenerative medicine, and the body’s innate capacity to heal, illustrating how advanced surgical innovation, tissue preservation, and biologically aligned therapies are redefining outcomes across modern healthcare.

From Surgical Precision to Regenerative Innovation

Dr. Bruce Werber’s medical journey is grounded in rigorous training and global clinical experience. After earning his Doctor of Podiatric Medicine from the California College of Podiatric Medicine, he pursued advanced international fellowships in Russia, Greece, and Israel, refining his expertise in complex limb reconstruction. Over decades in private practice, he became a leading authority in limb salvage, Charcot reconstruction, and congenital deformities, while also dedicating 25 years to global surgical missions treating underserved children worldwide.

Innovation at the Intersection of Surgery and Biotechnology

Driven to extend healing beyond the operating room, Dr. Werber transitioned into biotechnology and regenerative science. A prolific inventor with multiple U.S. patents, he earned a Master’s degree in Regenerative Medicine and Tissue Engineering and went on to found and lead several successful biotech companies. His work has focused on translating placental tissue science into clinically effective therapies, helping scale regenerative solutions from concept to real-world application.

Advancing Regenerative Biologics and Clinical Education

Today, Dr. Werber specializes in the translational science of placental-derived biologics, including mesenchymal stem cells, exosomes, and neuromodulatory therapies. As CEO of BioXtek and an adjunct professor of surgery, he continues to advance regenerative medicine through research, product development, and physician education—bridging innovation, biology, and patient-centered care.

Why “Bye Ol’ Dentistry” Aligns with Regenerative Medicine

Dr. Werber’s participation in “Bye Ol’ Dentistry” reinforces the film’s core premise: lasting healing begins by addressing the biological systems that connect localized damage to whole-body dysfunction. Drawing from decades of experience in limb preservation and regenerative therapeutics, he offers a systems-level perspective on inflammation, tissue repair, and the body’s innate capacity to regenerate when supported by biologically aligned care.

“Bye Ol’ Dentistry” unites leading clinicians, researchers, and innovators to illuminate the essential link between oral health and systemic performance. Through Dr. Werber’s lens, the documentary expands dentistry beyond the mouth, positioning biological dentistry as a critical pillar within regenerative healthcare, where precision medicine, biologics, and foundational healing principles converge to redefine long-term wellness.